SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 462.38 |
| Enterprise Value ($M) | 225.20 |
| Book Value ($M) | 261.87 |
| Book Value / Share | 9.67 |
| Price / Book | 1.77 |
| NCAV ($M) | 222.03 |
| NCAV / Share | 8.20 |
| Price / NCAV | 2.08 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.22 |
| Return on Assets (ROA) | -0.14 |
| Return on Equity (ROE) | -0.22 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.76 |
| Current Ratio | 4.76 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 330.82 |
| Assets | 370.65 |
| Liabilities | 108.79 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Nikko Asset Management Americas, Inc. | 8.56 | 75.31 | |
| 13G | Sumitomo Mitsui Trust Holdings, Inc. | 8.56 | 75.31 | |
| 13G/A | BlackRock, Inc. | 10.20 | 14.37 | |
| 13G/A | Vanguard Group Inc | 5.46 | 0.55 | |
| 13G/A | ARK Investment Management LLC | 7.66 | 1.75 | |
| 13G/A | State Street Corp | 6.10 | -2.29 | |
| 13G/A | Federated Hermes, Inc. | 17.63 | 11.13 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 142,496 | 452,119 | 31.52 | |
| 120,275 | 353,241 | 34.05 | |
| 112,206 | 380,352 | 29.50 | |
| 218,195 | 557,715 | 39.12 | |
| 342,672 | 873,450 | 39.23 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| APGE – Apogee Therapeutics, Inc. | APLT – Applied Therapeutics, Inc. |
| AQST – Aquestive Therapeutics, Inc. | ARDX – Ardelyx, Inc. |
| ATAI – Atai Life Sciences N.V. |
Financial data and stock pages provided by
Fintel.io